home | Website Reputation | Service Application Form
evaluation
  • Run into the paper statistics, helpless. On Qimo, I saw that Dr.Tong company provided the assistance of thesis statistics, and with the guidance and assistance of the doctor's teacher, I ran smoothly to get the results. Thank Dr.Tong for his high-level service.
    Mr. Lin
    from: tainan
  • When a doctoral dissertation encounters multiple linear regression, it has always been a difficult point and there is nothing to do. On Google, we can see that the doctor teacher of Dr.Tong statistics company provides statistical running and statistical guidance. The information and requirements to the doctor teacher, with the help of the teacher, smoothly run out the results. Thank you for the help and guidance from the doctor of Dr.Tong statistics company.
    Dr. Li
    from: taoyuan
  • When I met the difficulties in the statistical analysis of the doctoral thesis questionnaire, I couldn't find a clue. Finally, I saw Dr.Tong's assistance in the statistical analysis of the thesis questionnaire on qimo.com. With the assistance of the doctor, I got the results smoothly. Thank Dr.Tong for his assistance in the statistical analysis of the thesis questionnaire, which solved my urgent problem.
    Dr. Li
    from: Kaohsiung
  • Previously, a local statistics company in Hong Kong was entrusted, but it failed to do a good job in medical statistics. In my anxiety, I saw the doctor teacher of Dr.Tong statistics company provide statistical running and guidance, and sent the data and requirements to the doctor teacher. With the efforts of the doctor teacher, the analysis results were successfully made. I feel that Taiwan's statistics companies are more professional and the fees are reasonable.
    Dr. Li
    from: hongkong
  • Thank you for the efficient and high quality service provided by the doctor teacher of Dr.Tong statistics company. Solved my urgent need.
    Mr. Lin
    from: yunlin
  • When I met the difficulties in the statistical analysis of the pre-test and post-test of the thesis questionnaire, I couldn't solve them all the time. On Qimo, I saw that the doctoral teacher of Dr.Tong statistics company provided the tutoring service of thesis statistics, and sent the information and requirements to the doctoral teacher. With the help and guidance of the teacher, I got the results. Thank you very much for the tutoring service of the doctoral teacher of Dr.Tong statistics company There are two difficulties.
    Miss Liu
    from: Kaohsiung
  • It is difficult to analyze English papers by SPSS. On Google, we can see that the doctoral teacher of Dr.Tong statistics company provides the paper statistics running and guidance, sends the data and analysis requirements to the teacher, communicates with the teacher, and runs smoothly with the teacher's guidance and help. Thank you very much for the help of the doctor teacher of Dr.Tong statistics company. The teacher is serious, responsible and powerful.
    Miss Zeng
    from: london
  • It's difficult to analyze Stata data in accounting papers. On Yahoo Qimo, I saw the doctor teacher of Dr.Tong statistics company provide Stata statistical running guidance. The data and requirements were sent to the doctor's teacher. Under the guidance of the doctor's teacher, the Stata code was successfully designed, and the analysis results were also run out. I would like to thank the doctor's teacher of Dr.Tong statistics for his high level guidance and assistance.
    Mr. Zhang
    from: taizhong
  • Educational papers have quantitative statistics, which is a bit difficult! Helpless, I saw on Yahoo Qimo that Dr. and postdoctoral teachers from Dr.Tong Statistics Company provide doctoral thesis statistics and counseling services. I sent the questionnaire and sample data to the doctor, and with the guidance and assistance of the doctor, I successfully obtained the results and graduated. I am very grateful for the professional guidance of the doctor and postdoctoral teacher from Dr.Tong Statistics Company. The technical expertise, reliable quality, and reasonable fees have saved me a lot of trouble.
    Dr. Song
    from: Kaohsiung
2021-11-05 04:20:33 | onclick: | Britain took the lead in approving the use of Merck oral anti neocrown drugs

The British drug and health products administration announced on the 4th that it has approved the oral anti new crown drug monabilavir developed by Merck in the United States for specific new crown patients. This is the world's first anti Xinguan oral drug.

The British drug and health products administration said in a communique 4 days that the head of the new crown has been approved for mild to moderate symptoms. These patients have at least one risk factor for worsening of the disease, including obesity, over 60 years of age, diabetes and heart disease.

It is a small molecule broad-spectrum antiviral oral drug directed against RNA virus, which is developed by Merck Co and Rich Barker biopharmaceutical company of the United States. It inhibits COVID-19 replication. According to the interim analysis data of phase III clinical trial released by Merck in early October, the drug can reduce the risk of hospitalization or death of patients with mild to moderate symptoms by about 50%.

The communique said that the human drugs Committee, an independent expert advisory group of British regulators and the government, has strictly reviewed its safety, quality and effectiveness, making it the first oral antiviral drug approved for the treatment of new crown infection. The communique quoted British health secretary said Javed as saying that for the most vulnerable and immunosuppressed patients, approving the drug will "change the rules of the game", and these people will soon be able to receive breakthrough treatment.

The UK is the first country in the world to officially approve the use of monabilavir in the treatment of patients with new crowns. The European Drug Administration said on October 5 that it would consider starting the rapid approval of monabilavir. Merck submitted an application for emergency use authorization of the drug to the U.S. Food and Drug Administration in October.

  Leave a message
Email: *
Phone: *
Verification Code:
  Latest message
[ LIST | TOP ]